• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

RAS mutation linked with survival in metastatic colorectal cancer

bys25qthea
September 21, 2013
in Chronic Disease, Gastroenterology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: CC/Wiki

1. Patients with colorectal liver metastases (CLM) with a RAS gene mutation were more likely to have cancer recurrence and had lower 3-year survival. 

2. Cancer recurrence in the lung was associated with RAS status, while liver recurrence was not. 

Evidence Rating Level: 2 (Good)            

Study Rundown: In this retrospective cohort study, authors used curative resection specimens from patients with hepatic colorectal metastases to demonstrate an association between RAS mutation and survival as well as cancer recurrence. Strengths of this study include robust sample size and narrow study criteria that only included patients with one round of preoperative chemotherapy with specific agents, thus ensuring participant homogeneity. Though 1406 consecutive CLM patients were treated at MD Anderson, only data from 193 patients was analyzed. The results are thus more difficult to generalize to many CLM patients who receive multiple rounds of preoperative chemotherapy or concomitant radiofrequency ablation.

Click to read the study in Annals of Surgery

Relevant Reading: KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer

RELATED REPORTS

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

Shortened duration of adjuvant chemotherapy in individuals with stage III colon cancer may be associated with noninferior overall survival

#VisualAbstract: Pembrolizumab linked to longer cancer-free period in advanced MSI-H-dMMR colorectal cancer

In-Depth [retrospective cohort]: This study analyzed the RAS mutation status of 193 patients with curatively resected hepatic colorectal metastases between 1997 and 2011 with a median follow-up time of 33 months. All patients underwent one round of preoperative chemotherapy. Following laparotomy the resected specimens were examined for somatic mutations using Sequenom’s MassARRAY system. Forty-three patients (22.3%) had a mutation in one the genes assayed and 34 patients (17.6%) were positive for a RAS mutation. Patients with a RAS mutation has lower recurrence-free survival (RFS) at three years compared to patients with wild-type RAS (13.5% vs. 33.5%, p=0.001) and worse overall survival at three years (52.2% vs. 81%, p=0.002). RAS mutation along with poor pathologic response to neoadjuvant chemotherapy were identified as independent risk factors for RFS and overall survival. Tumor recurrence in the lung was also associated with RAS mutation, while liver metastases recurrence was not correlated with RAS status.

By Asya Ofshteyn and Allen Ho

More from this author: Bariatric surgery linked to reversal of diabetes, Postoperative readmission rates correlated with length of stay and ASA class, Prompt surgery may yield better outcomes for adhesive small bowel obstruction, Immediate cholecystectomy preferred treatment for acute cholecystitis, Living donor outcomes improved by motivational interviewing

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: colon cancer
Previous Post

Statin use linked to increased risk of cataracts

Next Post

Local excision inferior to major resection in T1-2 colon cancer and T2 rectal cancer

RelatedReports

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Chronic Disease

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

March 20, 2023
Racial differences in colorectal cancer survival linked to health at initial diagnosis
2 Minute Medicine

Shortened duration of adjuvant chemotherapy in individuals with stage III colon cancer may be associated with noninferior overall survival

June 2, 2021
#VisualAbstract: Occult Blood in Feces Is Associated With an Increased Risk of Ischemic Stroke and Myocardial Infarction
Chronic Disease

#VisualAbstract: Pembrolizumab linked to longer cancer-free period in advanced MSI-H-dMMR colorectal cancer

January 28, 2021
Radiofrequency ablation of hepatic metastases in colorectal cancer linked with improved survival
Gastroenterology

Addition of bevacizumab to standard therapy improves outcomes in metastatic colorectal cancer

August 31, 2020
Next Post
Reducing surgical complications may increase costs

Local excision inferior to major resection in T1-2 colon cancer and T2 rectal cancer

Breastfeeding associated with decreased risk of childhood obesity

Postnatal breastfeeding concerns associated with discontinuation

Mortality after trauma increasingly due to preexisting conditions

Minorities under-treated in pediatric emergency departments

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options